MeSH tree: C14.280.484.048.750
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely to die or experience ...
Mar 31, 2025
0
12
Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling stroke at five years compared ...
Mar 31, 2025
0
15
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated.
Mar 31, 2025
0
8
Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's main pumping chamber, become abnormally thick. "HCM is one of the primary causes of sudden death ...
Mar 20, 2025
0
14
A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, called aortic valve stenosis, progresses differently in males and females. The research reveals that ...
Mar 20, 2025
0
17
Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how aortic valve size is associated with the degree of valve calcification in severe aortic stenosis (AS).
Mar 12, 2025
0
16
It's often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in one in 500 people.
Feb 27, 2025
0
16
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides interventional cardiologists, cardiothoracic surgeons, and heart teams with practical guidance for ...
Feb 25, 2025
0
12
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ataciguat to manage AVS.
Feb 24, 2025
0
20
More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. Additionally, data from the Statistical Update ...
Feb 24, 2025
0
17
